Immunophenotyping in multiple myeloma and related plasma cell disorders

被引:89
|
作者
Kumar, Shaji [1 ]
Kimlinger, Teresa
Morice, William
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
关键词
monoclonal gammopathy; myeloma; plasma cell; immunophenotyping; MULTIPARAMETER FLOW-CYTOMETRY; MINIMAL RESIDUAL DISEASE; LOW CD27 EXPRESSION; HIGH-DOSE THERAPY; BONE-MARROW; PERIPHERAL-BLOOD; MONOCLONAL GAMMOPATHY; LABELING INDEXES; UNDETERMINED SIGNIFICANCE; C-KIT;
D O I
10.1016/j.beha.2010.09.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma cell disorders form a spectrum ranging from the asymptomatic presence of small monoclonal populations of plasma cells to conditions like plasma cell leukemia and multiple myeloma, in which the bone marrow can be replaced by the accumulation of neoplastic plasma cells. Immunophenotyping has become an invaluable tool in the management of hematological malignancies and is increasingly finding a role in the diagnosis and monitoring of plasma cell disorders. Multiparameter flow cytometry has evolved considerably during the past decade with an increasing ability to screen large numbers of events and to detect multiple antigens at the same time. This, along with a better understanding of the phenotypic heterogeneity of the clonal plasma cells in different disorders, has made immunophenotyping an indispensible tool in the diagnosis, prognostic classification and management of plasma cell disorders. This book chapter addresses the approaches taken to evaluate monoclonal plasma cell disorders, and the different markers and techniques that are important for the study of these diseases. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:433 / 451
页数:19
相关论文
共 50 条
  • [31] CANCER (MULTIPLE-MYELOMA AND RELATED DISORDERS)
    KATZIN, WE
    ANALYTICAL CHEMISTRY, 1993, 65 (12) : R382 - R387
  • [32] EVALUATION AND TREATMENT OF MULTIPLE MYELOMA AND RELATED DISORDERS
    SALMON, SE
    ARIZONA MEDICINE, 1974, 31 (09) : 660 - 663
  • [33] Neurological aspects of multiple myeloma and related disorders
    Dispenzieri, A
    Kyle, RA
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (04) : 673 - 688
  • [34] PLASMA-CELL DNA CONTENT IN MULTIPLE-MYELOMA AND RELATED PARAPROTEINEMIC DISORDERS - RELATIONSHIP WITH CLINICAL AND CYTOKINETIC FEATURES
    MONTECUCCO, C
    RICCARDI, A
    MERLINI, G
    MAZZINI, G
    GIORDANO, P
    DANOVA, M
    ASCARI, E
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (01): : 81 - 90
  • [35] Multiple myeloma of the plasma cell type
    Wood, AC
    Lucke, B
    ANNALS OF SURGERY, 1923, 78 : 14 - 25
  • [36] Plasma cell differentiation and multiple myeloma
    Shapiro-Shelef, M
    Calame, K
    CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (02) : 226 - 234
  • [37] Plasma cell emperipolesis in multiple myeloma
    Bento, Laiz Cameirao
    Nogueira, Bruna Garcia
    de Freitas Centuriao, Newton
    Hamerschlak, Nelson
    Souto, Elizabeth Xisto
    Bacal, Nydia Strachman
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (06) : 937 - 937
  • [38] Plasma Cell Myeloma and Related Neoplasms
    Lorsbach, Robert B.
    Hsi, Eric D.
    Dogan, Ahmet
    Fend, Falko
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 136 (02) : 168 - 182
  • [39] Plasma cell leukemia is an unusual manifestation of multiple myeloma related to poor prognosis
    Delisle, V
    Tollis, F
    Truchan-Graczyk, M
    Rousselet-Chapeau, MC
    Ifrah, N
    Zandecki, M
    Geneviève, F
    ANNALES DE BIOLOGIE CLINIQUE, 2002, 60 (01) : 89 - 95
  • [40] Current and potential applications of positron emission tomography for multiple myeloma and plasma cell disorders
    Ulaner, Gary A.
    Landgren, C. Ola
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (01)